In November 2002 11 leading life sciences research organizations united their intellectual, organizational and material resources, establishing Non Commercial Partnership – “The Center of Modern Medical Technology “, TEMPO (Technology, Epidemiology, Marketing, Production). NP “TEMPO” combined organizations of different property forms including 7 state organizations (4 state scientific centers) and 4 joint companies, which are leaders in Russia in the field of microbiology, biotechnology, gene engineering, molecular biology and immunology, diagnostics and indication with highly professional experts. Foreign articles and diplomas of international exhibitions prove high priority of NP “TEMPO” members. TEMPO members's staff of 5500 consists of highly professional experts, namely 5 Academician of the Russian Academy of Sciences, 2 corresponding members of the Russian Academy of Sciences, 55 academicians of the Russian Academy of Medical Sciences, 29 corresponding members of the Russian Academy of Medical Sciences, 65 academicians of branch academies, 586 Dr. of Science, 1513 candidates of Science, 3 Lenin Prize Winners, and 44 State Prize Winners. TEMPO has made great progress in almost four years since it's founding, establishing a network of contacts in the domestic and foreign pharmaceutical and biotechnology business worlds:
Now TEMPO combines 18 organizations, which are leading scientific centers of Russia in the field of microbiology, biotechnology, genetic engineering, molecular biology and immunology, diagnostics and indication with highly professional experts.
Microgene, a consortium of seventeen Russian biotechnology production facilities, joined TEMPO in 2005: a testament to TEMPO's growing reputation in domestic industry.
St. Petersburg State Medical University named by Academician I. P. Pavlov joined TEMPO in 2005. The main activities of the University are: preclinical trials, molecular medicine and immunology, molecular genetics, epidemiology, medical prophylaxis and social diseases (HIV/AIDS, IDU, tuberculosis), transplantology and cell therapy, pharmacoepidemiology and pharmacoeconomy.
Institute of Toxicology joined TEMPO in 2005. Main activities are: pathogenesis of chemical intoxications and development of pharmaceuticals (antidotes).
The National Center of Biotehcnology of the Republic of Kazakhstan joined TEMPO in 2008 - http://www.biocenter.kz/
So TEMPO unites the organizations of Higher Education, Federal Service for Surveillance in Consumer Rights Protection & Human Well-being, Federal medico-biological agency, Russian Academy of sciences and Russian Academy of medical sciences, Joint Stock Companies, and Producaion.
The State Scientific CenterFederalState Unitary Enterprise “The State Scientific Research Institute of Biological Instrument Making” Federal medico-biological agency
The FederalState Unitary Enterprise “Research-Production Unit on Medico-immunobiological Preparations “Microgene” of the Russian Ministry of Health and Social Development
In November 2002 11 leading life sciences research organizations united their intellectual, organizational and material resources, establishing Non Commercial Partnership – “The Center of Modern Medical Technology “, TEMPO (Technology, Epidemiology, Marketing, Production). NP “TEMPO” combined organizations of different property forms including 7 state organizations (4 state scientific centers) and 4 joint companies, which are leaders in Russia in the field of microbiology, biotechnology, gene engineering, molecular biology and immunology, diagnostics and indication with highly professional experts. Foreign articles and diplomas of international exhibitions prove high priority of NP “TEMPO” members. TEMPO members's staff of 5500 consists of highly professional experts, namely 5 Academician of the Russian Academy of Sciences, 2 corresponding members of the Russian Academy of Sciences, 55 academicians of the Russian Academy of Medical Sciences, 29 corresponding members of the Russian Academy of Medical Sciences, 65 academicians of branch academies, 586 Dr. of Science, 1513 candidates of Science, 3 Lenin Prize Winners, and 44 State Prize Winners. TEMPO has made great progress in almost four years since it's founding, establishing a network of contacts in the domestic and foreign pharmaceutical and biotechnology business worlds:
Now TEMPO combines 18 organizations, which are leading scientific centers of Russia in the field of microbiology, biotechnology, genetic engineering, molecular biology and immunology, diagnostics and indication with highly professional experts.
Microgene, a consortium of seventeen Russian biotechnology production facilities, joined TEMPO in 2005: a testament to TEMPO's growing reputation in domestic industry.
St. Petersburg State Medical University named by Academician I. P. Pavlov joined TEMPO in 2005. The main activities of the University are: preclinical trials, molecular medicine and immunology, molecular genetics, epidemiology, medical prophylaxis and social diseases (HIV/AIDS, IDU, tuberculosis), transplantology and cell therapy, pharmacoepidemiology and pharmacoeconomy.
Institute of Toxicology joined TEMPO in 2005. Main activities are: pathogenesis of chemical intoxications and development of pharmaceuticals (antidotes).
The National Center of Biotehcnology of the Republic of Kazakhstan joined TEMPO in 2008 - http://www.biocenter.kz/
So TEMPO unites the organizations of Higher Education, Federal Service for Surveillance in Consumer Rights Protection & Human Well-being, Federal medico-biological agency, Russian Academy of sciences and Russian Academy of medical sciences, Joint Stock Companies, and Producaion.
The State Scientific CenterFederalState Unitary Enterprise “The State Scientific Research Institute of Biological Instrument Making” Federal medico-biological agency
The FederalState Unitary Enterprise “Research-Production Unit on Medico-immunobiological Preparations “Microgene” of the Russian Ministry of Health and Social Development
